Thoracic Outlet Obstruction 

  • Author: Mark K Eskandari, MD; Chief Editor: Vincent Lopez Rowe, MD   more...
 
Updated: Mar 12, 2012
 

History of the Procedure

Thoracic outlet syndrome (TOS) has been an important clinical entity for more than a century. In 1821, Sir Astley Cooper first described axillary–subclavian artery symptoms due to compression from a cervical rib. In 1875, James Paget described the clinical symptoms resulting from subclavian vein thrombosis (eg, arm swelling, pain). In 1884, von Schroetter correctly attributed these upper extremity venous symptoms to thrombosis or compression of the subclavian vein at the thoracic outlet. Consequently, venous thrombosis at the thoracic outlet is known as venous TOS or Paget-Schroetter syndrome.

Next

Problem

Thoracic outlet syndrome (TOS) has distinct clinical pictures (ie, neurogenic, arterial, venous) caused by compression of the neurovascular structures at the thoracic outlet. The classification is based on which structure is primarily involved.

Previous
Next

Epidemiology

Frequency

Neurogenic thoracic outlet syndrome (TOS) is the most common presentation, occurring in approximately 95% of patients. Arterial TOS is the next most common presentation and occurs in about 2-3% of patients who are affected. Venous TOS is the least common, representing only 1-2% of patients with TOS.

Approximately 70% of patients with neurogenic TOS are females aged 20-50 years. Venous TOS occurs with a male-to-female ratio of 2:1.

Previous
Next

Etiology

The potential for either neurologic or vascular compression exists at the thoracic outlet. When compression occurs, one of the thoracic outlet syndromes (TOSs) may develop. Neurogenic and arterial TOS result from compression that occurs in the scalene triangle, as depicted in the 1st image below, and venous TOS results from compression in the costoclavicular space, as depicted in the 2nd image below.[1]

Thoracic outlet obstruction. Scalene triangle. Thoracic outlet obstruction. Scalene triangle. Thoracic outlet obstruction. Costoclavicular spaceThoracic outlet obstruction. Costoclavicular space.
Previous
Next

Pathophysiology

Neurogenic thoracic outlet syndrome (TOS) most commonly is associated with a history of neck trauma. Swollen and scarred muscles or aberrant scalene anatomy can irritate cords of the brachial plexus locally and lead to the neurologic symptoms.

Arterial TOS often is associated with cervical ribs or a rudimentary first rib.[2, 3] This aberrant anatomy leads to repeated intermittent arterial compression coinciding with arm movement. This repetitive localized trauma leads to intimal lesions, focal arterial stenosis, poststenotic dilatation, aneurysmal change, and subsequent thromboembolic complications. The second portion of the subclavian artery, which has a retroscalene position, often is the site of positional compression and stricture.

Venous TOS usually results from compression of the subclavian vein by the subclavius muscle and costoclavicular ligament.[4] When local structures are placed in abnormal or unaccustomed positions by extremes of activity or injury, vein compression and subsequent vein thrombosis can result. Venous TOS tends to occur in the more active dominant extremity. Arterial and venous TOS usually are associated with certain predisposing anatomic abnormalities, while neurogenic TOS is more likely to result following traumatic injury.

Previous
Next

Presentation

Neurogenic thoracic outlet syndrome (TOS) is a clinical diagnosis that only is made when objective findings are supported by subjective symptoms and physical findings. Other diagnoses that should be considered include tendonitis, fibromyalgia, cervical disc herniation, spinal stenosis, carpal tunnel syndrome, repetitive motion syndrome, and epicondylitis.

A history of a motor vehicle collision (MVC) or other neck trauma is usually elicited, and patients may report a variety of symptoms, such as neck, shoulder, and arm pain. Symptoms of compression from all cords of the brachial plexus are the most common neurologic pattern noted with TOS.

Previous authors have written that ulnar nerve involvement is the typical pattern of symptoms related to neurogenic TOS, but this is not the case. Paresthesias and weakness in an arm, occipital headaches, and paraspinal muscle pain are common. The paraspinal muscle pain and occipital headaches are secondary to referred nerve pain. As expected, specific symptoms coincide with the area of the brachial plexus that is compressed. On physical examination, symptoms usually can be reproduced with pressure on the scalenes and with abduction/external rotation (AER) of the arms. Coldness and color changes in the hand usually are secondary to sympathetic nerve involvement rather than arterial involvement.

Focus the examination on the neurologic and vascular findings. Carefully examine the scalene muscles and supraclavicular fossa for abnormal pulsations, bruits, and pain with palpation. Examine all upper extremity pulses, and perform provocative positioning during the vascular examination. Also seek petechiae and other evidence of embolic events.

The mean age of patients with arterial TOS at presentation is approximately 10 years older than patients with neurogenic symptoms. Occasionally, arterial TOS is recognized during workup for other pathologies. An incidental pulsatile mass or a supraclavicular bruit may be noted during thorough physical examination. Unfortunately, arterial TOS usually remains unrecognized until a thromboembolic complication occurs. Patients who embolize may present with hand claudication, gangrene, and other embolic stigmata.

In 80% of cases of venous TOS, the dominant extremity is involved. The diagnosis is based on the clinical presentation of upper extremity swelling, venous engorgement, and pain. These signs and symptoms, in association with radiologic documentation of venous compression at the thoracic outlet, confirm the diagnosis of Paget-Schroetter syndrome. Sometimes, venous compression cannot be demonstrated, and the diagnosis is made clinically and by the pattern of venous thrombosis.

Pulmonary embolism has been reported in patients with primary venous thrombosis, but this more commonly occurs in patients presenting with secondary venous thrombosis. Secondary venous thrombosis occurs due to processes such as malignancy, polycythemia vera, heart failure, infection, drug abuse, thrombocytosis, estrogens, and most commonly, central venous catheters and indwelling cardiac pacing wires. Upper extremity deep venous thrombosis (DVT) accounts for 1-4% of all DVTs, and primary venous thrombosis accounts for 25% of these cases. Catheter-related DVTs account for most upper extremity DVTs.

Previous
Next

Indications

The indication for surgical treatment of neurogenic thoracic outlet syndrome (TOS) is the failure of conservative treatment in a patient with disability so severe that the patient is unable to work or live comfortably. The indication for surgical treatment of venous TOS is controversial but based on symptomatology and venographic evidence of compression at the thoracic outlet. Arterial TOS, however, in most circumstances should be treated surgically with first rib resection and arterial repair.

Previous
Next

Relevant Anatomy

The relevant anatomy of thoracic outlet syndrome (TOS) focuses on the scalene triangle and the costoclavicular space. Reports of compression of the neurovascular bundle at the area of the pectoralis minor space exist, but this is very uncommon and shall not be discussed further.

Neurogenic and arterial TOS result from compression that occurs in the scalene triangle, which is defined by the first rib, the anterior scalene muscle, and the middle scalene muscle. The subclavian artery and the branches of the brachial plexus pass through the borders of this triangle, as depicted in the image below.

Thoracic outlet obstruction. Scalene triangle. Thoracic outlet obstruction. Scalene triangle.

Venous TOS occurs secondary to compression that occurs in the costoclavicular space. The borders of the costoclavicular space are the first rib, costoclavicular ligament, subclavius muscle, and the anterior scalene. As the subclavian vein passes through this space, it is susceptible to compression by these structures, as depicted in the image below. Other important local structures include the phrenic nerve, the lateral thoracic nerve, and the thoracic duct. The phrenic nerve passes from lateral to medial along the anterior border of the anterior scalene muscle, and the lateral thoracic nerve passes through the body of the middle scalene muscle. The thoracic duct joins cervical lymphatics and drains into the superior aspect of the jugulosubclavian vein confluence behind the left sternocleidomastoid muscle. Be careful to avoid injury to these structures during surgery.

Thoracic outlet obstruction. Costoclavicular spaceThoracic outlet obstruction. Costoclavicular space.

Search for cervical, rudimentary, or broad first ribs. Resect these structures during surgical therapy. Rudimentary ribs usually arise higher in the neck than normal first ribs and typically articulate with the second rib rather than with the sternum. Cervical ribs and rudimentary first ribs occur in less than 0.5% of the population.

Abnormal scalene muscle anatomy also has been identified and may be a cause of some symptoms. For example, these muscles have been noted to interdigitate around the cords of the brachial plexus and, thus, have been implicated in the irritation of the cords of the brachial plexus. In a study of 98 meticulously dissected cadavers, the authors noted a number of abnormalities of the thoracic outlet fibrous bands and cervical ribs, and other abnormalities were found in most of the patients. Only 10% of the dissected cadavers were found to have normal anatomy bilaterally.

Previous
Next

Contraindications

No absolute contraindication to the treatment of patients with thoracic outlet syndrome (TOS) exists. An individual patient may have significant comorbidities that outweigh the benefits of surgical repair and thus have a relative contraindication to surgery.

Previous
Proceed to Workup
 
 
Contributor Information and Disclosures
Author

Mark K Eskandari, MD  the James T Yao Professor of Education in Vascular Surgery, Chief, Division of Surgery-Vascular, Associate Professor, Division of Surgery-Vascular and Medicine-Cardiology and Cardiology, Northwestern University, The Feinberg School of Medicine; Attending Surgeon, Division of Vascular Surgery, Northwestern Memorial Hospital; Consulting Staff, Division of Vascular Surgery, Northwestern Medical Faculty Foundation; Consulting Staff, Department of Surgery, Lake Forest Hospital

Mark K Eskandari, MD is a member of the following medical societies: American College of Surgeons, American Medical Association, Association for Academic Surgery, Cardiovascular and Interventional Radiological Society of Europe, Central Surgical Association, International Society of Endovascular Specialists, Peripheral Vascular Surgery Society, Society for Clinical Vascular Surgery, Society for Vascular Surgery, Society of Interventional Radiology, Society of University Surgeons, Southern Association for Vascular Surgery, and Western Surgical Association

Disclosure: Harvard Clinical Research Honoraria Consulting; Medtronic Honoraria Consulting; Abbott Vascular Honoraria Consulting

Coauthor(s)

Nicholas D Garcia, MD  Chief of Surgery, Exeter Hospital; Director, Board of Directors, Core Physician Services; Associate Medical Director, Core Physicians, LLC

Nicholas D Garcia, MD is a member of the following medical societies: American College of Surgeons, New Hampshire Medical Society, and Society for Vascular Surgery

Disclosure: Nothing to disclose.

Mark D Morasch, MD  Professor of Surgery, Division of Vascular Surgery, John Marquardt Clinical Research Professor in Vascular Surgery, Northwestern University, The Feinberg School of Medicine

Mark D Morasch, MD is a member of the following medical societies: American College of Surgeons, American Heart Association, American Medical Association, American Venous Forum, Central Surgical Association, Peripheral Vascular Surgery Society, Society for Clinical Vascular Surgery, Society for Vascular Surgery, and Western Surgical Association

Disclosure: W.L. Gore & Associates Honoraria Speaking and teaching

Specialty Editor Board

Jeffrey Lawrence Kaufman, MD  Associate Professor, Department of Surgery, Division of Vascular Surgery, Tufts University School of Medicine

Jeffrey Lawrence Kaufman, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Surgeons, American Society for Artificial Internal Organs, Association for Academic Surgery, Association for Surgical Education, Massachusetts Medical Society, Phi Beta Kappa, and Society for Vascular Surgery

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Vincent Lopez Rowe, MD  Associate Professor of Surgery, Department of Surgery, Division of Vascular Surgery, University of Southern California Medical Center Program Director, Vascular Surgery Residency

Vincent Lopez Rowe, MD is a member of the following medical societies: American College of Surgeons, American Heart Association, Pacific Coast Surgical Association, Peripheral Vascular Surgery Society, Society for Clinical Vascular Surgery, Society for Vascular Surgery, and Western Vascular Surgical Society

Disclosure: Nothing to disclose.

Paolo Zamboni, MD  Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy

Paolo Zamboni, MD is a member of the following medical societies: American Venous Forum and New York Academy of Sciences

Disclosure: Nothing to disclose.

Chief Editor

Vincent Lopez Rowe, MD  Associate Professor of Surgery, Department of Surgery, Division of Vascular Surgery, University of Southern California Medical Center Program Director, Vascular Surgery Residency

Vincent Lopez Rowe, MD is a member of the following medical societies: American College of Surgeons, American Heart Association, Pacific Coast Surgical Association, Peripheral Vascular Surgery Society, Society for Clinical Vascular Surgery, Society for Vascular Surgery, and Western Vascular Surgical Society

Disclosure: Nothing to disclose.

Additional Contributors

The authors and editors of eMedicine gratefully acknowledge the contributions of previous author Hassan Tehrani, MB, BCh, to the development and writing of this article.

References
  1. Machleder HI, Moll F, Verity MA. The anterior scalene muscle in thoracic outlet compression syndrome. Histochemical and morphometric studies. Arch Surg. Oct 1986;121(10):1141-4. [Medline].

  2. Kemp CD, Rushing GD, Rodic N, McCarthy E, Yang SC. Thoracic outlet syndrome caused by fibrous dysplasia of the first rib. Ann Thorac Surg. Mar 2012;93(3):994-6. [Medline].

  3. Dubuisson A, Lamotte C, Foidart-Dessalle M, Nguyen Khac M, Racaru T, Scholtes F, et al. Post-traumatic thoracic outlet syndrome. Acta Neurochir (Wien). Mar 2012;154(3):517-26. [Medline].

  4. Davidovic LB, Koncar IB, Pejkic SD, Kuzmanovic IB. Arterial complications of thoracic outlet syndrome. Am Surg. Mar 2009;75(3):235-9. [Medline].

  5. Shalhub S, Starnes BW, Hatsukami TS, Karmy-Jones R, Tran NT. Repair of blunt thoracic outlet arterial injuries: an evolution from open to endovascular approach. J Trauma. Nov 2011;71(5):E114-21. [Medline].

  6. AbuRahma AF, Sadler D, Stuart P, Khan MZ, Boland JP. Conventional versus thrombolytic therapy in spontaneous (effort) axillary-subclavian vein thrombosis. Am J Surg. Apr 1991;161(4):459-65. [Medline].

  7. Adams JT, DeWeese JA. "Effort" thrombosis of the axillary and subclavian veins. J Trauma. Nov 1971;11(11):923-30. [Medline].

  8. Adelman MA, Stone DH, Riles TS, Lamparello PJ, Giangola G, Rosen RJ. A multidisciplinary approach to the treatment of Paget-Schroetter syndrome. Ann Vasc Surg. Mar 1997;11(2):149-54. [Medline].

  9. Arko FR, Harris EJ, Zarins CK, Olcott C 4th. Vascular complications in high-performance athletes. J Vasc Surg. May 2001;33(5):935-42. [Medline].

  10. Axelrod DA, Proctor MC, Geisser ME, Roth RS, Greenfield LJ. Outcomes after surgery for thoracic outlet syndrome. J Vasc Surg. Jun 2001;33(6):1220-5. [Medline].

  11. Caparrelli DJ, Freischlag J. A unified approach to axillosubclavian venous thrombosis in a single hospital admission. Semin Vasc Surg. Sep 2005;18(3):153-7. [Medline].

  12. Cheng SW, Stoney RJ. Supraclavicular reoperation for neurogenic thoracic outlet syndrome. J Vasc Surg. Apr 1994;19(4):565-72. [Medline].

  13. Cormier JM, Amrane M, Ward A, Laurian C, Gigou F. Arterial complications of the thoracic outlet syndrome: fifty-five operative cases. J Vasc Surg. Jun 1989;9(6):778-87. [Medline].

  14. Gelabert HA, Machleder HI. Diagnosis and management of arterial compression at the thoracic outlet. Ann Vasc Surg. Jul 1997;11(4):359-66. [Medline].

  15. Gergoudis R, Barnes RW. Thoracic outlet arterial compression: prevalence in normal persons. Angiology. Aug 1980;31(8):538-41. [Medline].

  16. Green RM, McNamara J, Ouriel K. Long-term follow-up after thoracic outlet decompression: an analysis of factors determining outcome. J Vasc Surg. Dec 1991;14(6):739-45; discussion 745-6. [Medline].

  17. Hagspiel KD, Spinosa DJ, Angle JF, Matsumoto AH. Diagnosis of vascular compression at the thoracic outlet using gadolinium-enhanced high-resolution ultrafast MR angiography in abduction and adduction. Cardiovasc Intervent Radiol. Mar-Apr 2000;23(2):152-4. [Medline].

  18. Hill SL, Berry RE. Subclavian vein thrombosis: a continuing challenge. Surgery. Jul 1990;108(1):1-9. [Medline].

  19. Juvonen T, Satta J, Laitala P, Luukkonen K, Nissinen J. Anomalies at the thoracic outlet are frequent in the general population. Am J Surg. Jul 1995;170(1):33-7. [Medline].

  20. Landry GJ, Moneta GL, Taylor LM Jr, Edwards JM, Porter JM. Long-term functional outcome of neurogenic thoracic outlet syndrome in surgically and conservatively treated patients. J Vasc Surg. Feb 2001;33(2):312-7; discussion 317-9. [Medline].

  21. Lang EK. Scalenus anticus and pectoralis minor syndrome. J Indiana State Med Assoc. Apr 1967;60(4):440. [Medline].

  22. Lee WA, Hill BB, Harris EJ Jr, Semba CP, Olcott C IV. Surgical intervention is not required for all patients with subclavian vein thrombosis. J Vasc Surg. Jul 2000;32(1):57-67. [Medline].

  23. Lindgren KA, Oksala I. Long-term outcome of surgery for thoracic outlet syndrome. Am J Surg. Mar 1995;169(3):358-60. [Medline].

  24. Lokanathan R, Salvian AJ, Chen JC, Morris C, Taylor DC, Hsiang YN. Outcome after thrombolysis and selective thoracic outlet decompression for primary axillary vein thrombosis. J Vasc Surg. Apr 2001;33(4):783-8. [Medline].

  25. Machleder HI. Evaluation of a new treatment strategy for Paget-Schroetter syndrome: spontaneous thrombosis of the axillary-subclavian vein. J Vasc Surg. Feb 1993;17(2):305-15; discussion 316-7. [Medline].

  26. Molina JE, Hunter DW, Dietz CA. Paget-Schroetter syndrome treated with thrombolytics and immediate surgery. J Vasc Surg. Feb 2007;45(2):328-34. [Medline].

  27. Monreal M, Lafoz E, Ruiz J, Valls R, Alastrue A. Upper-extremity deep venous thrombosis and pulmonary embolism. A prospective study. Chest. Feb 1991;99(2):280-3. [Medline].

  28. Monreal M, Raventos A, Lerma R. Pulmonary embolism in patients with upper extremity DVT associated to venous central lines--a prospective study. Thromb Haemost. Oct 1994;72(4):548-50. [Medline].

  29. Nakada T, Knight RT, Mani RL. Intermittent venous claudication of the upper extremity: the pectoralis minor syndrome. Ann Neurol. Apr 1982;11(4):433-4. [Medline].

  30. Nehler MR, Taylor LM Jr, Moneta GL, Porter JM. Upper extremity ischemia from subclavian artery aneurysm caused by bony abnormalities of the thoracic outlet. Arch Surg. May 1997;132(5):527-32. [Medline].

  31. Novak CB, Collins ED, Mackinnon SE. Outcome following conservative management of thoracic outlet syndrome. J Hand Surg [Am]. Jul 1995;20(4):542-8. [Medline].

  32. Parziale JR, Akelman E, Weiss AP. Thoracic outlet syndrome. Am J Orthop. May 2000;29(5):353-60. [Medline].

  33. Rutherford RB, Hurlbert SN. Primary subclavian-axillary vein thrombosis: consensus and commentary. Cardiovasc Surg. Aug 1996;4(4):420-3. [Medline].

  34. Sanders RJ, Cooper MA, Hammond SL, et al. Neurogenic thoracic outlet syndrome. In: Gloviczki P, et al, eds. Rutherford Vascular Surgery. 5th ed. Philadelphia, Pa:. W.B. Saunders Company;2000:1184-1201.

  35. Sanders RJ, Hammond SL. Subclavian vein obstruction without thrombosis. J Vasc Surg. Feb 2005;41(2):285-90. [Medline].

  36. Sanders RJ, Haug CE, Pearce WH. Recurrent thoracic outlet syndrome. J Vasc Surg. Oct 1990;12(4):390-8; discussion 398-400. [Medline].

  37. Sanders RJ, Huag CE. Thoracic Outlet Syndrome: A Common Sequela of Neck Injuries. Philadelphia, Pa:. JB Lippincott;1991.

  38. Sanders RJ, Pearce WH. The treatment of thoracic outlet syndrome: a comparison of different operations. J Vasc Surg. Dec 1989;10(6):626-34. [Medline].

  39. Schneider DB, Dimuzio PJ, Martin ND. Combination treatment of venous thoracic outlet syndrome: open surgical decompression and intraoperative angioplasty. J Vasc Surg. Oct 2004;40(4):599-603. [Medline].

  40. Sheeran SR, Hallisey MJ, Murphy TP, Faberman RS, Sherman S. Local thrombolytic therapy as part of a multidisciplinary approach to acute axillosubclavian vein thrombosis (Paget-Schroetter syndrome). J Vasc Interv Radiol. Mar-Apr 1997;8(2):253-60. [Medline].

  41. Southam AH, Bythell WJ. Cervical ribs in children. Br Med J. 1924;2:844-55.

  42. Szeimies U, Kueffer G, Stoeckelhuber B. Successful exclusion of subclavian aneurysms with covered nitinol stents. Cardiovasc Intervent Radiol. May-Jun 1998;21(3):246-9. [Medline].

  43. Thompson RW, Schneider PA, Nelken NA, Skioldebrand CG, Stoney RJ. Circumferential venolysis and paraclavicular thoracic outlet decompression for "effort thrombosis" of the subclavian vein. J Vasc Surg. Nov 1992;16(5):723-32. [Medline].

  44. Urschel HC Jr, Razzuk MA. Improved management of the Paget-Schroetter syndrome secondary to thoracic outlet compression. Ann Thorac Surg. Dec 1991;52(6):1217-21. [Medline].

  45. Wilson JJ, Zahn CA, Newman H. Fibrinolytic therapy for idiopathic subclavian-axillary vein thrombosis. Am J Surg. Feb 1990;159(2):208-10; discussion 210-1. [Medline].

Previous
Next
 
Thoracic outlet obstruction. Scalene triangle.
Thoracic outlet obstruction. Costoclavicular space.
Thoracic outlet obstruction. Three-dimensional CT scan showing subclavian artery at the thoracic outlet.
Thoracic outlet obstruction. Three-dimensional CT scan showing subclavian artery with the arm abducted.
Thoracic outlet obstruction. CT scan, maximal intensity projection (MIP), showing subclavian artery in the neutral position.
Thoracic outlet obstruction. CT scan, maximal intensity projection (MIP), showing subclavian artery when arm is abducted.
Thoracic outlet obstruction. CT scan, maximal intensity projection (MIP), showing subclavian vein in neutral position.
Thoracic outlet obstruction. CT scan, maximal intensity projection (MIP), showing subclavian vein in abducted position.
Thoracic outlet obstruction. Angiogram showing subclavian artery aneurysm in abduction/external rotation (AER).
Thoracic outlet obstruction. Venogram showing venous stenosis.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.